CANNABINOID TREATMENT POTENTIAL FOR SLEEP APNOEA

摘要

Positive airway pressure is the primary treatment for obstructive sleep apnoea (OSA), but it is associated with poor long-term adherence. In a study in Sleep (7 November 2017), researchers explored the efficacy of dronabinol, a cannabinoid primarily used to treat nausea and vomiting in people receiving chemotherapy.